i don't think anyone would disagree that these results are quite spectacular.
Getting ANYTHING to be statistically significant is autism is difficul because of the broad range in symptoms and severity. Just ask NEU holders.
NTI need to get this information out there.
Do they have any conferences, meetings, etc coming up?
Surely if the spread this around, interest will build. I can't imagine anyone interested in treatments for ASD could ignore this.
Only my opinion of course.
NTI Price at posting:
26.5¢ Sentiment: Buy Disclosure: Held
